CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Serve First›
Analysis
Serve First logo

Serve First

Serve First provides customer feedback surveys and staff engagement platforms.

Milton Keynes, England, GB🇬🇧
Founded
2023
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Library

Contents

  1. 01Competitive Strengths
  2. 02Competitive Landscape
  3. 03Growth Drivers
  4. 04Market Outlook
  5. 05Executive Summary
  6. 06Products & Services
  1. 01Competitive Strengths
  2. 02Competitive Landscape
  3. 03Growth Drivers
  4. 04Market Outlook
  5. 05Executive Summary
  6. 06Products & Services

Competitive Advantages

Serve First’s strongest advantage over broad CX platforms such as Qualtrics is workflow proximity: it connects multi-site customer signals to a frontline owner and tracks corrective action through completion. Its platform brings together in-store surveys, online reviews, mystery shopping, audits and brand-standard checks, making execution rather than survey volume its central distinction for distributed operators.

The advantage has early enterprise validation, though the evidence shows traction rather than a proven moat against Qualtrics or Medallia. In 2025, Serve First tripled ARR over the prior 12 months, doubled UK headcount and added Alphega Pharmacy, Aramark and Elior Group; by 2026 its pharmacy deployment covered more than 2,500 locations across seven countries, extending the implementation experience relevant to multi-site buyers.

Competitive Landscape

Serve First holds a focused operational-CX position against enterprise platforms such as Qualtrics and Medallia: its multi-site workflow joins feedback, audits and frontline corrective action, while Qualtrics spans customer and employee interactions with AI agents. The trade-off is specialization versus suite breadth; Qualtrics processed more than 3.5 billion interactions annually in 2026, while Serve First’s 2025 customer set included Aramark, Elior Group and Alphega Pharmacy.

Serve First’s strongest differentiation is deployment breadth, not a demonstrated price advantage. In 2026, its pharmacy rollout spanned over 2,500 locations in seven countries alongside a £5 million growth round, giving it a concrete international use case; this is narrower in scope than the broad CX platforms but directly tests the multi-site execution workflow it sells.

Growth Drivers

Serve First’s clearest growth lever is scaling multi-site customers internationally, a more tangible near-term path than category growth alone against Qualtrics and Medallia. In 2025, ARR tripled over the preceding 12 months and a £4.6 million round backed expansion into Europe and the US; in 2026, a pharmacy rollout covered more than 2,500 locations in seven countries.

Product expansion from feedback management into operational assurance could widen usage within existing accounts, although it remains an execution opportunity rather than a proven growth driver. Serve First’s 2026 offering included camera-based evidence of cleaning rounds and hazard alerts for facilities management, while its £5 million growth round was intended to support sales hiring and further AI investment; adoption across more sites will determine whether this broadens its position against larger CX suites.

Market Outlook

Category development favors platforms that close the loop from listening to operational response, but it also raises the competitive bar against Qualtrics and Medallia as they add AI-led action. Qualtrics’ 2026 account said its platform processed more than 3.5 billion customer and employee interactions annually and that over a third of its customer base had adopted its AI capabilities; Serve First’s more focused multi-site workflow therefore competes in a market where automation is moving from differentiation toward table stakes.

Serve First’s international opportunity is supported by customer expansion, while the scale of broader demand remains a forecast rather than an assured outcome. Mercia cited a 2024–2029 customer-experience-management market forecast of 15.7% annual growth in 2025, and 2026 funding coverage described a rollout covering over 2,500 pharmacies in seven countries; sustained growth depends on converting such deployments into repeatable adoption beyond the initial enterprise accounts.

Memo

The investment thesis is that Serve First can win multi-location operators by linking CX measurement to frontline execution more tightly than broad alternatives such as Qualtrics and Medallia. Its early commercial signal was strong: in 2025, ARR tripled over the preceding 12 months, with Alphega Pharmacy, Aramark and Elior Group among its customers; by 2026, ARR exceeded £2 million, headcount was 25 and a £5 million growth round was funding sales and product investment.

The thesis must withstand larger suites moving into automated insight-to-action: Qualtrics reported in 2026 that more than a third of its customers had adopted AI capabilities, across a platform processing over 3.5 billion annual interactions. Serve First’s 2026 pharmacy rollout across 2,500-plus locations in seven countries offers a path to repeatable international deployments, but the case depends on translating that footprint and new capital into sustained enterprise expansion.

Product Overview

Serve First sits between feedback-led CX suites such as Qualtrics and Medallia and frontline operations: its differentiating job is to turn multi-site signals into assigned, tracked fixes rather than stop at measurement. Its current platform combines surveys, public reviews, mystery shopping, audits and brand-standard checks in one view, then routes corrective work to site teams; in 2025, Mercia described the same feedback-to-action product serving retail, hospitality, wellness and facilities management customers.

The product’s delivery case is operational breadth across locations, not a disclosed price or quantified service-level advantage over the larger suites. In 2025, Mercia named Alphega Pharmacy, Aramark and Elior Group as customers and reported that Serve First had tripled annual recurring revenue in the preceding 12 months; its 2026 funding coverage described a European pharmacy rollout spanning more than 2,500 pharmacies in seven countries, evidence that the workflow was being taken beyond a UK-only footprint.